Kopran Limited vs Zydus Lifesciences Limited
A side-by-side comparison of Kopran Limited (KOPRAN) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Zydus Lifesciences Limited leads KOPRAN vs ZYDUSLIFE on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth02
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ZYDUSLIFE takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
ZYDUSLIFE takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
ZYDUSLIFE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has been maintaining a healthy dividend payout of 56.3%"]
- − ["The company has delivered a poor sales growth of 6.7% over past five years.", "The company has delivered a poor profit growth of -16.1% over past five years.", "Company has a low return on equity of 7.9% over last 3 years."]
- + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.